Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma (HBV-HCC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Sun Yat-sen University.
Recruitment status was  Recruiting
Information provided by:
Sun Yat-sen University Identifier:
First received: July 21, 2008
Last updated: February 6, 2009
Last verified: February 2009